US15117B2025
US15117B2025
Celldex Therapeutics, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.545.000 | 7.020.000 | 78.0% |
| Cost of Revenue | -- | -- | -- |
| Gross Profit | -- | -- | -- |
| 288.912.000 | 202.098.000 | 43.0% | |
| Operating Income | -287.367.000 | -195.078.000 | 47.3% |
| Pretax Income | -258.757.000 | -157.863.000 | 63.9% |
| Net Income Common Stockholders | -258.757.000 | -157.863.000 | 63.9% |
| -- | -- | -- | |
| -- | -- | -- |